Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

From TechCrunch

By Amanda Silberling

November 2, 2024

Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

Bonobos founder Andy Dunn is back in the builder’s seat, working on an in-person social media platform called Pie. But the biggest lessons he learned from his $310 million Bonobos exit don’t have as much to do with entrepreneurship as they do with staying sane.

When Dunn was in college, he was diagnosed with bipolar disorder, but he didn’t get adequate treatment until 2016, when he was hospitalized during a manic episode for the second time.

“The manic state is just a disaster — that’s like being in psychosis, you know, messianic delusions. … You can’t accomplish anything in that state,” Dunn said onstage at TechCrunch Disrupt 2024. The incident was enough of a wakeup call that 16 years after his initial diagnosis, he finally took his condition seriously and started going to therapy, taking medication, and monitoring his sleep.

Dunn wrote a book called “Burn Rate: Launching a Startup and Losing My Mind,” documenting the parallel processes of building Bonobos and figuring out how to accept and then manage his bipolar disorder. But the lessons from the book are applicable for entrepreneurs beyond those with Dunn’s diagnosis.

“We all have mental health, right? It doesn’t take a diagnosis to suffer or struggle,” he said.

Still, entrepreneurs tend to report a higher incidence of mental health issues throughout their lives than the average person.

“There’s definitely a correlation between neurodivergence and creativity,” he said. “I don’t know if entrepreneurship attracts people who are neurodivergent, or it makes them more neurodivergent, but there’s certainly some kind of a virtuous and sometimes unvirtuous cycle there.”

That interplay between mental illness and entrepreneurship is even more palpable for Dunn, who says that the state of hypomania — the high of bipolar disorder, as opposed to the crushing depressive periods — could be conducive to running a startup.

“Here are the DSM criteria for [hypomania]: rapid speech, increased ideation, grandiosity, decreased need for sleep, ability to be more creative … more or less the central casting traits of an entrepreneur having a good day,” he said. “I was able to benefit from that, but the price that I paid was ultimately too high. I was depressed with suicidal ideation for between two to three months a year, and then ultimately, the full mania and psychosis came raging back, which was catastrophic.”

But even in an astonishingly productive hypomanic state, Dunn doesn’t think he was the greatest boss or colleague. He said that one of the side effects of hypomania is becoming irritable when people disagree with you, which is essential to running a collaborative company. Now, running Pie, Dunn welcomes this debate.

“When we disagree, let’s go, let’s disagree even more, because we’re going to be able to make a better decision coming out of it,” he said.

While discussions about mental health have become more mainstream, founders still worry about the stigma of revealing a diagnosis to colleagues and investors. Dunn is an adviser to the Founder Mental Health Pledge, which asks investors to advocate for the mental health of the founders they invest in. But he’s not naive that the stigma is still present — when founders ask for his advice about when to disclose a mental health concern to investors, he says to wait six weeks until after the deal closes.

“We raised $125 million at Bonobos — would you give $125 million to someone who can either be psychotic or catatonically depressed?” Dunn said. “But also, you shouldn’t do what I did and hide it, because then, you know, when there is a crisis, it’s a surprise.”

Dunn’s discussion of his experience with bipolar disorder doesn’t seem to have hurt his ability to fundraise, though — Pie just raised a $11.5 million Series A. As public as he is about the severity of bipolar disorder, he’s also open about how his regimen of therapy and medication have helped him live a stable life.

“I treat bipolar as my Olympic regimen. For Simone Biles, it’s how to navigate and win the gold,” he said. “For me, the gold medal is to die of something else, right? Because the horrible thing about bipolar is the suicide rate.”

Now, the next test for Dunn is to do the work it takes to make Pie a success without sacrificing his stability.

“Here’s the challenge,” Dunn said. “We want to have good mental health, and we want our teams to have balance in mental health, and yet a 40-hour workweek doesn’t cut it. You can’t change the world with a bunch of people working 40 hours a week.”

One way Dunn has navigated this fine line is to be open with job candidates about what the work will entail, as well as how he will support them with company benefits.

“I have a new spiel I give when recruiting, which is, this is a 50- to 60-hour-per-week job, and in return, you’re going to get two awesome things. One, you’re going to learn more and grow more and develop more. Two, you’ve got equity,” he said.

Like any startup leader, Dunn wants his team to work hard, but he believes there’s a way to do that without it backfiring. In describing his time at Bonobos in “Burn Rate,” Dunn writes, “I came to a classic mistaken conclusion of an immature startup founder: if the business isn’t working, then we must not be working hard enough.”

There’s no denying that founders need to work hard — but taking care of oneself is part of that hard work.

View original article on techcrunch.com

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

How to build a company while protecting your mental health

How to build a company while protecting your mental health

Everyone knows that it is stressful to build a company. And it’s just as commonly known that endless chronic work can lead to burnout. So, why don’t we talk more about founder mental health?Now that our culture is more comfortable discussing mental health in general, it’s time we brought the topic to Disrupt for a thorough interrogation.Watch as Andy Dunn, the CEO of Pie and Co-Founder of Bonobos, discusses how to build a company while protecting your mental health. Subscribe for more on YouTub

Oct 29, 2024

A new $25M fund aims to give UK mental health startups a shot in the arm

A new $25M fund aims to give UK mental health startups a shot in the arm

In case you hadn’t noticed, there are a lot of mental health startups out there these days, many of which were prompted to launch following the pandemic and the subsequent widespread focus on mental health. However, they often have scant relationships with clinical trials or healthcare systems. A new venture from the U.K.’s KHP Ventures, is planning to correct that by raising a new £20 million ($25.5 million) fund specifically aimed at accelerating startups that are addressing depression, anxi

Dec 12, 2024

How Pilea helps founders break down stigma around mental health

How Pilea helps founders break down stigma around mental health

There hasn’t been a ton of research on the prevalence of mental health issues among founders, but what there is speaks loudly.

Aug 15, 2023

XP Health grabs $32M to bring employees more affordable vision care

XP Health grabs $32M to bring employees more affordable vision care

Antonio Moraes, the grandson of a late prominent Brazilian billionaire, was never interested in joining the family-owned conglomerate of construction companies and a bank. Shortly after graduating from college, he founded one of Brazil’s first impact funds, which invested primarily in companies that made healthcare more accessible and affordable. But while attending Stanford University, where Moraes received a master’s in business administration and healthcare policy, he realized that instead o

Sep 12, 2024

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

How to build a company while protecting your mental health

How to build a company while protecting your mental health

Everyone knows that it is stressful to build a company. And it’s just as commonly known that endless chronic work can lead to burnout. So, why don’t we talk more about founder mental health?Now that our culture is more comfortable discussing mental health in general, it’s time we brought the topic to Disrupt for a thorough interrogation.Watch as Andy Dunn, the CEO of Pie and Co-Founder of Bonobos, discusses how to build a company while protecting your mental health. Subscribe for more on YouTub

Oct 29, 2024

A new $25M fund aims to give UK mental health startups a shot in the arm

A new $25M fund aims to give UK mental health startups a shot in the arm

In case you hadn’t noticed, there are a lot of mental health startups out there these days, many of which were prompted to launch following the pandemic and the subsequent widespread focus on mental health. However, they often have scant relationships with clinical trials or healthcare systems. A new venture from the U.K.’s KHP Ventures, is planning to correct that by raising a new £20 million ($25.5 million) fund specifically aimed at accelerating startups that are addressing depression, anxi

Dec 12, 2024

How Pilea helps founders break down stigma around mental health

How Pilea helps founders break down stigma around mental health

There hasn’t been a ton of research on the prevalence of mental health issues among founders, but what there is speaks loudly.

Aug 15, 2023

XP Health grabs $32M to bring employees more affordable vision care

XP Health grabs $32M to bring employees more affordable vision care

Antonio Moraes, the grandson of a late prominent Brazilian billionaire, was never interested in joining the family-owned conglomerate of construction companies and a bank. Shortly after graduating from college, he founded one of Brazil’s first impact funds, which invested primarily in companies that made healthcare more accessible and affordable. But while attending Stanford University, where Moraes received a master’s in business administration and healthcare policy, he realized that instead o

Sep 12, 2024